Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 1, 2013, Pages 59-60

  Lotta, Luca A ^a   Wu, Haifeng M ^b   Cairo, Andrea ^a   Bentivoglio, Giorgio ^c   Peyvandi, Flora ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE DISEASE; ADULT; ALLERGIC REACTION; ARTERIAL PRESSURE; BLOOD CELL COUNT; BRONCHOSPASM; CASE REPORT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC PAIN; ETHNIC GROUP; FATIGUE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEADACHE; HUMAN; ITALIAN; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; WESTERN BLOTTING;

ACUTE DISEASE; ADAM PROTEINS; ADULT; EXONS; FEMALE; HUMANS; MUTATION; PREGNANCY; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84869865487     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.08.001     Document Type: Letter

References (9)

1. Schulman I., Pierce M., Lukens A., Currimbhoy Z. Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency. Blood 1960, 16:943-957.
2. Levy G.G., Nichols W.C., Lian E.C., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001, 413:488-494.
3. Lotta L.A., Garagiola I., Palla R., Cairo A., Peyvandi F. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum. Mutat. 2010, 31:11-19.
4. Fujimura Y., Matsumoto M., Isonishi A., et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J. Thromb. Haemost. 2011, 9(Suppl. 1):283-301.
5. Lotta L.A., Wu H.M., Mackie I.J., et al. Residual plasmatic activity of ADAMTS13 correlates with phenotype severity in congenital thrombotic thrombocytopenic purpura. Blood 2012, 120:440-448.
6. Lotta L.A., Mariani M., Consonni D., et al. Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura. Br. J. Haematol. 2010, 151:488-494.
7. Lotta L.A., Lombardi R., Mariani M., et al. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission. J. Thromb. Haemost. 2011, 9:1744-1751.
8. Lotta L.A., Wang M., Yu J., et al. Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. BMC Med. Genomics 2012, 5:7.
9. Mannucci P.M., Canciani M.T., Forza I., et al. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001, 98:2730-2735.